pharmaceutical investing Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo Phase 1 Combination Trial
Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets
Pinnacle Silver and Gold Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025